Alterations in DNA methylation are early, but not initial, events in ovarian tumorigenesis.

[1]  J. Felix,et al.  Potential role of the inactivated X chromosome in ovarian epithelial tumor development. , 1996, Journal of the National Cancer Institute.

[2]  R. Beart,et al.  Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. , 1995, Cancer research.

[3]  A. Balmain Cancer: Exploring the bowels of DNA methylation , 1995, Current Biology.

[4]  W. Benedict,et al.  Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas. , 1995, Journal of the National Cancer Institute.

[5]  M. Rudnicki,et al.  MyoD expression marks the onset of skeletal myogenesis in Myf-5 mutant mice. , 1994, Development.

[6]  J. Herman,et al.  Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[7]  G. Coetzee,et al.  Progressive increases in the methylation status and heterochromatinization of the myoD CpG island during oncogenic transformation , 1994, Molecular and cellular biology.

[8]  J. Goodman,et al.  Alterations in the methylation status and expression of the raf oncogene in phenobarbital‐induced and spontaneous B6C3F1 mouse liver tumors , 1994, Molecular carcinogenesis.

[9]  Rudolf Jaenisch,et al.  Role for DNA methylation in genomic imprinting , 1993, Nature.

[10]  S. Baylin,et al.  Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors. , 1993, Cancer research.

[11]  R. Kurman,et al.  The behavior of serous tumors of low malignant potential: are they ever malignant? , 1993, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[12]  S. Baylin,et al.  Altered chromosomal methylation patterns accompany oncogene-induced transformation of human bronchial epithelial cells. , 1993, Cancer research.

[13]  John Calvin Reed,et al.  bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. , 1993, Blood.

[14]  Adrian Bird,et al.  The essentials of DNA methylation , 1992, Cell.

[15]  Rudolf Jaenisch,et al.  Targeted mutation of the DNA methyltransferase gene results in embryonic lethality , 1992, Cell.

[16]  B. Oostra,et al.  Trinucleotide repeat polymorphism in the androgen receptor gene (AR). , 1992, Nucleic acids research.

[17]  K. Bock,et al.  Site-specific hypomethylation of c-myc protooncogene in liver nodules and inhibition of DNA methylation by N-nitrosomorpholine. , 1991, Biochemical pharmacology.

[18]  S. Baylin,et al.  Abnormal methylation of the calcitonin gene marks progression of chronic myelogenous leukemia. , 1991, Blood.

[19]  T. Dryja,et al.  Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. , 1991, American journal of human genetics.

[20]  H. Radzun,et al.  Increased methylation of the c-fms protooncogene in acute myelomonocytic leukemias. , 1991, Pathobiology : journal of immunopathology, molecular and cellular biology.

[21]  A. Bird,et al.  High levels of De Novo methylation and altered chromatin structure at CpG islands in cell lines , 1990, Cell.

[22]  S. Tapscott,et al.  De novo methylation of the MyoD1 CpG island during the establishment of immortal cell lines. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[23]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[24]  L. Dubeau,et al.  Loss of heterozygosity on chromosomal segments 3p, 6q and 11p in human ovarian carcinomas. , 1990, Oncogene.

[25]  L. Alhonen,et al.  Hypomethylation of ornithine decarboxylase gene and erb-A1 oncogene in human chronic lymphatic leukemia. , 1988, Blood.

[26]  L. Poirier,et al.  c-H-ras and c-K-ras gene hypomethylation in the livers and hepatomas of rats fed methyl-deficient, amino acid-defined diets. , 1988, Carcinogenesis.

[27]  A. Feinberg,et al.  Reduced genomic 5-methylcytosine content in human colonic neoplasia. , 1988, Cancer research.

[28]  H. Cedar,et al.  Regulation of mouse satellite DNA replication time. , 1988, The EMBO journal.

[29]  A. Bird CpG-rich islands and the function of DNA methylation , 1986, Nature.

[30]  H. Cedar,et al.  Effect of regional DNA methylation on gene expression. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[31]  A. Feinberg,et al.  Hypomethylation of DNA from benign and malignant human colon neoplasms. , 1985, Science.

[32]  A. Feinberg,et al.  Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors. , 1985, Science.

[33]  M. Ehrlich,et al.  Quantitative reversed-phase high-performance liquid chromatography of major and modified nucleosides in DNA. , 1984, Journal of chromatography.

[34]  M. Ehrlich,et al.  The 5-methylcytosine content of DNA from human tumors. , 1983, Nucleic acids research.

[35]  A. Feinberg,et al.  Hypomethylation distinguishes genes of some human cancers from their normal counterparts , 1983, Nature.

[36]  M. Ehrlich,et al.  5-Methylcytosine in eukaryotic DNA. , 1981, Science.

[37]  T. Mohandas,et al.  Reactivation of an inactive human X chromosome: evidence for X inactivation by DNA methylation. , 1981, Science.